IceCure Medical (ICCM)
(Real Time Quote from BATS)
$0.73 USD
+0.03 (4.78%)
Updated Jul 23, 2024 10:34 AM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Income Statements
Fiscal Year end for IceCure Medical Ltd falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 3 | 3 | 4 | 4 | 2 |
Cost Of Goods | 2 | 2 | 2 | 1 | 1 |
Gross Profit | 1 | 1 | 2 | 2 | 1 |
Selling & Adminstrative & Depr. & Amort Expenses | 17 | 18 | 12 | 7 | 5 |
Income After Depreciation & Amortization | -16 | -17 | -10 | -4 | -5 |
Non-Operating Income | 1 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -15 | -17 | -10 | -4 | -5 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -15 | -17 | -10 | -4 | -5 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -15 | -17 | -10 | -4 | -5 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -15 | -16 | -10 | -4 | -5 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -16 | -17 | -10 | -4 | -5 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 45.64 | 37.02 | 28.55 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.32 | -0.46 | -0.35 | NA | NA |
Diluted Net EPS (GAAP) | -0.32 | -0.46 | -0.35 | -0.22 | NA |
Fiscal Year end for IceCure Medical Ltd falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.74 | 1.26 | 0.33 | 0.94 |
Cost Of Goods | NA | 0.47 | NA | NA | NA |
Gross Profit | NA | 0.27 | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 3.92 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -3.65 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | 0.04 | NA | NA | NA |
Interest Expense | NA | 0.00 | NA | NA | NA |
Pretax Income | NA | -3.61 | NA | NA | NA |
Income Taxes | NA | 0.00 | NA | NA | NA |
Minority Interest | NA | 0.00 | NA | NA | NA |
Investment Gains/Losses | NA | 0.00 | NA | NA | NA |
Other Income/Charges | NA | 0.00 | NA | NA | NA |
Income From Cont. Operations | NA | -3.61 | -3.00 | -4.00 | -3.89 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -3.61 | -3.00 | -4.00 | -3.89 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 46.74 | 46.08 | 45.63 | 44.19 |
Diluted EPS Before Non-Recurring Items | NA | -0.08 | -0.07 | -0.09 | -0.09 |
Diluted Net EPS (GAAP) | NA | -0.08 | -0.07 | -0.09 | -0.09 |